UNITED THERAPEUTICS Corp 4

Tommy G. Thompson, a non-employee director of United Therapeutics Corporation, received 380 RSUs and options for 1,190 shares of common stock as part of his annual director equity award.

On July 22, 2026, non-employee director Tommy G. Thompson of United Therapeutics Corporation received an annual equity compensation package consisting of 380 restricted stock units and stock options for 1,190 shares, both recorded at a grant/transaction price of $0.00 as is typical for board awards. These RSUs and options vest on the earlier of June 25, 2027 or the date of the next annual shareholders’ meeting, and upon vesting each RSU will convert into one share of common stock. Following these awards, Thompson’s direct holdings increased to 8,480 shares of common stock, in addition to indirect holdings of 8,200 shares via a trust and 5,800 shares via a family LLC, and some of his reported common stock includes 880 shares recently issued from the vesting of previously deferred RSUs. The transactions are routine, compensation-related grants rather than open-market purchases or sales, and no sale of shares occurred in connection with this filing.

Filing Facts

CIK

1082554

Ticker

UTHR

Form

4

Source Type

fda

Accession

0001324863-26-000004

Alert Tier

5